Back to trial detailsIntake questionnaire
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Applying to ThedaCare Regional Cancer Center · Appleton, Wisconsin
Answer a few short questions to share with the research team.
0 of 4 answered